OTC · Healthcare · Biotechnology
ZIVO Bioscience, Inc.
ZIVO
ZIVO Bioscience, Inc. CEO John Bernard Payne · Market cap $12.6M.
$3.25
-0.50 · -13.33%
52w hi $19.6552w lo $1.11
Off 52w high 93.9%
60
NOTABLE
Current InsiderScore
Corp · 90d
2
2 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
2
1 strong · 1 notable
Analyst consensus
Strong Buy
Avg PT $12.00
Section 01
Recent Form 4 filings
8 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Apr 17 | Mark E Strome | Buy | 100,000 | $2.00 | +$200K | 60 | |
| Feb 12 | Mark E Strome | Buy | 20,000 | $9.77 | +$195K | 54 | |
| Jan 26 | Alison A Cornell | Buy | 11,709 | $8.54 | +$100K | 57 | |
| Jan 26 | John Bernard Payne | President and CEO | Buy | 11,709 | $8.54 | +$100K | 79 |
| Oct 13 | Mark E Strome | Buy | 20,259 | $12.34 | +$250K | 54 | |
| Oct 08 | Christopher D. Maggiore | Buy | 23,682 | $12.01 | +$284K | 54 | |
| Sep 30 | Laith L Yaldoo | Buy | 15,322 | $15.99 | +$245K | 54 | |
| Jun 13 | Laith L Yaldoo | Buy | 3,488 | $14.33 | +$50K | 35 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay